• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,583.22 -1,690.23
( -2.25%)
Global Indices
Nasdaq
45,202.56 -778.56
(-1.69%)
Dow Jones
6,394.42 -103.74
(-1.60%)
Hang Seng
53,412.46 -191.19
(-0.36%)
Nikkei 225
9,959.27 -12.90
(-0.13%)
Forex
USD-INR
94.09 0.23
(0.24%)
EUR-INR
108.64 -0.12
(-0.11%)
GBP-INR
125.57 -0.09
(-0.07%)
JPY-INR
0.59 0.00
(-0.07%)

EQUITY - MARKET SCREENER

Concord Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543960
INE338H01029
174.4719509
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CONCORDBIO
33.4
10608.61
EPS(TTM)
Face Value()
Div & Yield %
30.36
1
0.86
 

aqylon nexus ltd
Aqylon Nexus inks MoU with DataDirect Networks India
Mar 05,2026

Aqylon Nexus has executed a Memorandum of Understanding (MoU) with DataDirect Networks India, the world's leading AI data platform provider to explore strategic collaboration leading the development of AI-ready hyperscale data centres that will serve as the backbone of the nation's digital transformation.

The MoU has been executed with the objective of exploring potential strategic collaboration opportunities in the domains of Artificial Intelligence (AI) and Hyperscale Data Centre infrastructure.